KIF1A variants are a frequent cause of autosomal dominant hereditary spastic paraplegiaDepartment of Neurology, Leiden University Medical Center, The Netherlands.
Department of Human Genetics, Leiden University Medical Center, The Netherlands.
Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud university medical centre, Nijmegen, The Netherlands.
Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, The Netherlands.
Department of Neurology, Ikazia hospital, Rotterdam, The Netherlands.
Department of Clinical Genetics, Amsterdam UMC, Vrije Universtiteit Amsterdam, The Netherlands.
Department of Clinical Genetics, Amsterdam UMC, Vrije Universtiteit Amsterdam, The Netherlands.
Department of Clinical Genetics, Amsterdam UMC, University of Amsterdam, The Netherlands.
Department of Human Genetics and research Institute GROW, Maastricht University Medical Center, The Netherlands.
Department of Genetics, Utrecht University Medical Center, The Netherlands.
Department of Genetics, University Medical Center Groningen, University of Groningen, The Netherlands.
Department of Human Genetics, Radboud university medical centre, Nijmegen, The Netherlands.
Department of Pediatrics, The Queen Silvia Children’s Hospital, University of Gothenburg, Sweden.
Department of Clinical Genetics, Amsterdam UMC, University of Amsterdam, The Netherlands.
Department of Pediatric Neurology, Amsterdam UMC, University of Amsterdam, The Netherlands.
Department of Pediatric Neurology, Radboud University Medical Center, Amalia Children’s Hospital and Donders Institute for Brain, Cognition and Behavior, Nijmegen, The Netherlands.
Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud university medical centre, Nijmegen, The Netherlands.
Department of Human Genetics, Radboud university medical centre, Nijmegen, The Netherlands.
Show others and affiliations
2019 (English)In: European Journal of Human Genetics, ISSN 1018-4813, E-ISSN 1476-5438, Vol. 28, no 1, p. 40-49Article in journal (Refereed) Published
Place, publisher, year, edition, pages
Springer Nature, 2019. Vol. 28, no 1, p. 40-49
National Category
Medical Genetics and Genomics Neurosciences Neurology
Identifiers
URN: urn:nbn:se:his:diva-27118DOI: 10.1038/s41431-019-0497-zISI: 000502538900007PubMedID: 31488895Scopus ID: 2-s2.0-85073775799OAI: oai:DiVA.org:his-27118DiVA, id: diva2:2108153
Funder
EU, Horizon 2020, 668353
Note
CC BY 4.0
BPW is supported by research grants from Radboud university medical centre, ZonMW, Bioblast Pharma and Hersenstichting. EHB received funding for research on epilepsy genetics from the Stichting Panta Rhei, the Dutch Epilepsy Foundation, and the COFRA foundation. MK funding from the European Community’s Horizon 2020 Programme under grant agreement No.668353 (U-PGx). MAE receives funding from the Netherlands Organization for Health Research and Development (Veni scheme), The Thierry Latran Foundation, the ALS Foundation Netherlands and JPND, has consulted for Biogen and has received travel grants from Shire (formerly Baxalta). LHB reports grants from Netherlands ALS Foundation, grants from Prinses Beatrix Spierfonds, grants from Netherlands, Organization for Health Research and Development (Vici scheme), and personal fees from Baxter for scientific advisory board and travel grant, and personal fees from Scientific Advisory Board, Biogen Idec, outside the submitted work. No other authors have received any funding from any institution, including personal relationships, interests, grants, employment, affiliations, patents, inventions, honoraria, consultancies, royalties, stock options/ownership, or expert testimony for the last 12 months.
2026-10-062026-10-062026-10-07Bibliographically approved